The hippocampus is usually affected in primary dementias and the pathological changes may be severe. Knowledge of hippocampal pathology in HIV infection and Huntington's disease (HD), however, is extremely limited. A stereological technique (the optical "disector") has been used to assess neuronal populations in four areas of the hippocampus in 11 patients with HIV infection and in nine patients with HD. The HIV patients died without opportunistic infections or neoplasms affecting the brain; they had HIV encephalitis or minimal changes. The HD cases were all clinically diagnosed, had a positive family history and showed the characteristic lesions in the caudate nucleus. The neuronal counts were compared with those in nine controls. In the granule cell layer of the dentate, CA3 and CA4, there was no significant difference in the neuronal numerical density between the three groups. A striking difference between the HIV and HD groups was seen in the CAl region. The neuronal numerical density in the CAl area was significantly lower in the HD patients than in either the HIV patients or the controls (mean (SD) 37 5 (5.0); 70-1 (13-4); 57.9 (15.4) x 103 per mm3, p < 0001 (Students' t test)). This difference represents a neuronal loss of 35%. In all four hippocampal areas the neuronal density was higher in the HIV group than in the controls but the differences were not significant and can be explained by the higher average age of the control group. These findings contribute to the understanding of the mechanism of dementia in both AIDS and in Huntington's disease.
Damage to the nervous system is a major consequence of infection with human immunodeficiency virus 1 (HIV-1) which results in a variety of neurological manifestations. l 2Abnormalities in the central and peripheral nervous system are found at necropsy in over 95% of patients with the acquired immunodeficiency syndrome (AIDS).34 The most common neuropsychiatric disorder is HIV associated dementia,5 characterised by progressive cognitive impairment, personality change, and motor disturbance.' 6 The cause of this dementia has not been established. However, in many of those with HIV associated dementia, encephalitis is found at necropsy and one study has shown the degree of dementia to be directly associated with the severity of inflammation. 7 The role of this encephalitic process The nine Huntington's disease cases were selected from the brain collection in the Department of Neuropathology, Institute of Psychiatry. All subjects were clinically diagnosed as HD during life, had a positive family history, and post mortem examination of the brains showed the characteristic lesions in the caudate nucleus. The age of onset was known in seven of the cases [mean (SD) = 39-6 (16-2) years] and, excluding case 1 who committed suicide, the mean duration of the disease was 9 7 (4 5) years. The control group comprised nine patients: eight died of systemic illness, without cerebral pathology, whilst one had a pontine haemorrhage which did not affect the cerebral hemispheres. Although the cause of death in many of the subjects, in all groups, would have produced hypoxia there was no classic neuropathological evidence of anoxia (for example, pyknotic and eosinophilic neurons especially in CAl region of the hippocampus). Similar findings have been reported in HIV encephalitis by other workers.16
Although the HIV status of the HD group and controls could not be ascertained, none had any evidence of being in an at-risk group.
The mean (SD) age was 37-3 (7-6) in the HIV group, 50 3 (15.2) in the HD group and 47-2 (13-3) years in the controls, but the differences were not statistically significant. Fixed brain weights were known for 24 of the 29 subjects and there were no significant differences between the mean fixed brain weights of the three groups (table 1 shows patient details).
Blocks were taken from the hippocampus at the level of the lateral geniculate body. The tissue was embedded in paraffin wax, on a 5 day processing schedule. The resuldthg tissue shrinkage was about 10% of the section area, but it did not differ significantly between groups. Sections were cut at 20 ,um, stained with cresyl-violet and coded for assessment. Neuronal densities were quantified in the granule cell layer of the dentate, and in the CA1, CA3 and CA4 fields of the hippocampus. These anatomically discrete'7 areas were delineated in accord with an earlier study.'8 Quantitation was carried out using a stereological technique known as the optical "disector".19
Results
The neuronal numerical density in the four areas of the hippocampus for each subject are shown separately in tables 2-5, and group means are summarised in table 6. The mean neuronal numerical density for the control group is similar to reported values in a previous study that estimated neuronal numbers in the hippocampus. '8 Analysis of variance was carried out on the data for each of the subject groups for each area quantified and this shows a striking difference between the HIV infected subjects and those with Huntington's disease. In the HIV group there is no significant difference in the neuronal numerical density in any of the four areas quantified compared with that in the control group, although the mean neuronal density in all areas is consistently higher than in the controls. The striking and significant difference between the groups is seen in one region of the hippocampus. In the HD group the neuronal density in the CAl region (37.5 (5 0) x 103 per mm3) is significantly less (p < 0-001; Student's t test) than that observed in either the control (57 9 (15-4) x 103 per mm3) or HIV group (70-1 (13-4) x 103 per mm3 This difference represents a neuronal loss of some 35%. In the other regions quantified, the neuronal density in the HD group is not significantly different from the control or HIV group, although the mean values are consistently less than those in the controls.
An analysis of variance was carried out on the data for the two HIV subgroups and the control group. This showed that neither subgroup was significantly different from controls nor was there any significant difference between the subgroups in respect of any of the hippocampal regions quantified.
Discussion
This is the first quantitative study to have revealed cell loss of 35% in the hippocampus in HD and shows the changes to be restricted to area CAl. Little attention has been paid to hippocampal changes in HD, since an early study20 reported cell density to be normal. However, a more recent morphometric study of macroscopic sections from 30 cases of HD has reported a reduction of hippocampal area of some 20% compared with controls,12 and cited the early study20 as evidence of normal cell density. The authors explain this apparent discrepancy between reduction of area and normal neuronal density as being a result of a combination of neuronal loss and a proportionate tissue shrinkage. Moreover, one of the authors has stated elsewhere "to have been more impressed by the normality of the hippocampus than by any abnormality", 2' and commented that the use of sophisticated techniques may reveal changes in the hippocampus not yet detected. The present study which has used a recently developed technique for assessing neuronal density would support this statement since it has detected a reduction in neuronal density in one area of the hippocampus. In addition, since CAl accounts for,a substantial proportion of the total hippocampal volume,'8 a 35% reduction of neuronal density in CAl could account in part for the 20% reduction in hippocampal area previously reported. '2 In our study there are insufficient details to assess clinically the degree of dementia in the HD and HIV infected patients but the neuronal loss in HD is a potential cause of dementia. Huntington's disease,22 and more recently, HIV associated dementia,2 have both been clinically labelled as subcortical dementias. However, pathologically, the earlier studies9-1 showing neuronal loss in the frontal cortex in both conditions, together Although there is no significant difference in the neuronal numerical density, in any of the regions examined, between the HIV group and controls the values are consistently higher in the former group. This may be a reflection of the difference in the mean ages of the two groups. Although this difference is not significant, the mean for the HIV group is some 10 years less than the controls, and neurons decrease by some 3-6% per decade in the CAl region29 of the hippocampus.
The absence of hippocampal neuronal loss in the HIV group is interesting as it may provide an indication that the mechanism of cell damage in AIDS is different from that in HD, or may simply reflect a difference in duration of the disease processes. Although the duration of the symptoms is unknown in the HIV group, it is likely to be considerably shorter than the mean duration of 9 7 years in the HD group. Thus it is possible that the patients with HD died at an advanced stage of dementia by which time the hippocampus was involved, whereas the HIV patients died of other complications at an earlier stage of the disease before hippocampal involvement. Our study was retrospective and there is a paucity of information regarding the cognitive status of the patients. It is hoped, however, that a prospective study, being carried out at present, will address this problem.
These findings contribute to the understanding of the mechanism of dementia in both AIDS patients and in Huntington's disease and further delineate and quantify the extent of the neuropathological lesions in both conditions. It is anticipated that a further comparative study of selective neuronal loss in HIV infection and HD will lead to a better understanding of these diseases.
